共 50 条
- [2] Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products [J]. The AAPS Journal, 2017, 19 : 360 - 366
- [3] Bioavailability and bioequivalence in drug development [J]. WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL STATISTICS, 2014, 6 (04): : 304 - 312
- [4] Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products [J]. AAPS JOURNAL, 2017, 19 (02): : 360 - 366
- [5] FDA AND THE BIOEQUIVALENCE OF DRUG PRODUCTS [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1980, 180 (AUG): : 7 - MEDI
- [6] BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS IN DRUG APPLICATIONS IN SWEDEN [J]. ACTA PHARMACEUTICA SUECICA, 1978, 15 (04): : 311 - 311
- [7] BIOAVAILABILITY OF DRUG PRODUCTS [J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1973, NS13 (08): : 421 - 432
- [8] THE APPLICATION OF STABLE ISOTOPES TO STUDIES OF DRUG BIOAVAILABILITY AND BIOEQUIVALENCE [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (06): : 419 - 424